FDA.reportPublic FDA data

3CE TRIPLE SHADOW NO NONO

Manufacturer
Nanda Co., Ltd | Cosmax, Inc.
Effective date
2016-09-22
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:47:13

Label at a glance#

Product3CE TRIPLE SHADOW NO NONO
Active ingredientTitanium Dioxide
Label structure6 sections

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient: Titanium Dioxide 6.8%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Mica (CI 77019), Talc, Iron Oxides (CI 77491), Neopentyl Glycol Diethylhexanoate, Phenyl Trimethicone, Calcium Sodium Borosilicate, Glass, Nylon-12, Iron Oxides (CI 77499), Aluminum Powder (CI 77000), Methyl Methacrylate Crosspolymer, Diisostearyl Malate, Dipentaerythrityl Hexahydroxystearate/Hexastearate/Hexarosinate, Octyldodecyl Stearoyl Stearate, Isostearyl Neopentanoate, Synthetic Fluorphlogopite, Magnesium Myristate, Polypropylene, Polybutene, Propanediol, Magnesium Stearate, Aluminum Hydroxide, Dimethicone, Triethoxycaprylylsilane, PTFE, Tocopheryl Acetate, Silica, Tin Oxide (CI 77861), Sodium Dehydroacetate, Manganese Violet (CI 77742), Red 7 (CI 15850:1), Carmine (CI 75470), Iron Oxides (CI 77492), Chromium Hydroxide Green (CI 77289), Ferric Ferrocyanide (CI 77510)

PURPOSE

OTC - PURPOSE SECTION

Purpose: Sunscreen

CAUTION

WARNINGS SECTION

CAUTION: 1. Discontinue use and consult a doctor when - your skin irritates, swells, itches, shows spots on areas applied - your skin reacts similarly with above when exposed to sunlight 2. Avoid applying on wounded, irritated, troubled areas 3. After the use - keep the cap closed - keep it out of children's reach - keep it away from expose to sunlight, high and low temperatures

DESCRIPTION

DESCRIPTION SECTION

INSTRUCTIONS: Glittery and pigmented triple eye shadow that will give feminized eyes.

Directions: Layer/mix colors together and express different looks

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
60764-025-022020-01-31C16284748780-19d75b9cf-ea9e-f424-e053-dadaa90a57cea2ccf4e2-756f-49d0-9688-415d04836854

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
60764-025-013CE TRIPLE SHADOW NO NONO3.5 g in 1 CONTAINERPOWDER3.51
60764-025-023CE TRIPLE SHADOW NO NONO1 in 1 CARTONPOWDER11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
60764-0253CE TRIPLE SHADOW NO NONO (TITANIUM DIOXIDE) POWDER [NANDA CO., LTD]1Legacy NDC, 2 package rows20160922_a2ccf4e2-756f-49d0-9688-415d04836854.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
60764-02560764-025-01, 60764-025-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
Titanium Dioxide15FIX9V2JPACTIB
MicaV8A1AW0880IACT
Talc7SEV7J4R1UIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
e33bda00-75fa-499e-a6aa-b073339805a7a2ccf4e2-756f-49d0-9688-415d048368542016-09-22WarningsExact identifier
spl id: e33bda00-75fa-499e-a6aa-b073339805a7
spl set id: a2ccf4e2-756f-49d0-9688-415d04836854

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.